Philips partners with Dutch researchers to establish imaging institute

Philips Healthcare and three Dutch academic healthcare research institutions—University Medical Center Utrecht, Utrecht University and Eindhoven University of Technology—have signed a memorandum of understanding to establish a public-private consortium focused on developing new methods for disease diagnosis and treatment based on medical imaging.

The consortium will focus on treatments for cancer, brain disease and cardiovascular disease, as well as establish the Institute for Diagnostic and Interventional Imaging.

Knowledge, methodologies, software and technologies acquired through the consortium’s work will be translated into the industrial manufacturing of new systems that can be used in clinical practice. Philip’s development and production site in Best, the Netherlands, will be used to bring new technologies to market, and the partnership will be expanded in the future to include other private partners as well.
Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.